Tilray Stock Rises As Study Links Medical Cannabis To Lower Opioid Use - Tilray Brands (NASDAQ:TLRY)

Tilray Stock Rises As Study Links Medical Cannabis To Lower Opioid Use - Tilray Brands (NASDAQ:TLRY)

Tilray Brands Inc (NASDAQ:TLRY) shares are trading higher on Wednesday after a Marijuana Moment report cited findings from a new study showing medical cannabis legalization leads to significant reductions in opioid prescriptions. Here’s what investors need to know. • TLRY is among today’s top performers. Stay ahead of the curve here. What To Know: A study in the American Journal of Health Economics found medical cannabis legalization is "associa…

Legalizing Medical Marijuana Leads To ‘Significant Reductions’ In Opioid Prescriptions, Another Study Shows - Cannabis News World

Medical marijuana legalization is “associated with significant reductions in opioid prescribing,” yet another new study has found. Researchers at the University of Georgia and University of Colorado analyzed prescription claims for 15 to 20 million insured Americans annually from 2007-2020, comparing the prevalence of opioid prescriptions in states with and without medical cannabis programs in The post Legalizing Medical Marijuana Leads To ‘Sign…

Legalizing Medical Marijuana Leads To ‘Significant Reductions’ In Opioid Prescriptions, Another Study Shows

Medical marijuana legalization is "associated with significant reductions in opioid prescribing," yet another new study has found. Researchers at the University of Georgia and University of Colorado analyzed prescription claims for 15 to 20 million insured Americans annually from 2007-2020, comparing the prevalence of opioid prescriptions in states with and without medical cannabis programs in place. "We find that [medical cannabis laws, or MCLs…